Investigational drug may improve stem cell transplantation for multiple myeloma patients
A clinical trial led by the School of Medicine has shown that the investigational drug motixafortide — when combined with the standard therapy for mobilizing stem cells —may improve stem cell transplantation for multiple myeloma patients.
New imaging technology may reduce surgeries for rectal cancer patients
Quing Zhu, at the McKelvey School of Engineering, and Matthew Mutch, MD, at the School of Medicine, have been working together to develop a new imaging technology that can help doctors determine which colorectal cancer patients’ treatments have been successful, helping some to avoid surgery. Their efforts received a $1.75 million National Institutes of Health (NIH) grant.
Campbell to map network connections in the brains of Parkinson’s patients
Meghan Campbell, an associate professor of neurology and of radiology at the School of Medicine, and Caterina Gratton, of Florida State University, have received a five-year $3 million award from the National Institutes of Health (NIH) to image functional brain networks in people with Parkinson’s disease.
Grant supports training physician-scientists in cancer research
School of Medicine researchers have received a grant from the National Institutes of Health (NIH) to support training and mentorship for early-career physician-scientists. This funding opportunity will provide support for early-career physicians pursuing careers in cancer research.
WashU faculty awarded Taylor Geospatial Institute seed grants
Faculty from Arts & Sciences, the McKelvey School of Engineering and the School of Medicine received seed grants and other funding from the Taylor Geospatial Institute totaling more than $950,000. The grants are designed to encourage collaborative research and provide resources to advance geospatial science through innovative projects.
New approach targets norovirus, world’s leading cause of foodborne infection
Researchers at the School of Medicine have found a creative way to make a vaccine for norovirus, the leading cause of foodborne infections, by piggybacking on rotavirus, an unrelated virus for which there are already several highly effective vaccines.
Dahiya named to international brain tumor working committee
Neuropathologist Sonika Dahiya, MD, a professor of pathology and immunology and chief of the neuro-oncology section at the School of Medicine, has been named to the Working Committee of the Consortium to Inform Molecular and Practical Approaches to CNS Tumor Taxonomy.
COVID-19 patients’ blood plasma shows who is most likely to become severely ill
School of Medicine researchers have identified specific proteins that may help predict which COVID-19 patients may need to be placed on ventilators to breathe and which are most likely to die of the virus.
Solnica-Krezel honored for contributions to developmental biology
Lilianna Solnica-Krezel, the Alan A. and Edith L. Wolff Distinguished Professor and head of the Department of Developmental Biology at the School of Medicine, is to receive the 2023 Edwin G. Conklin Medal from the Society for Developmental Biology.
Keeping COVID-19 in check likely to require periodic boosters
Vaccinating people with updated boosters as new variants of the virus that causes COVID-19 emerge could shore up population immunity even as the virus mutates, according to School of Medicine research. Such action could prevent another deadly COVID-19 wave.
View More Stories